Eosinophils as a predictive marker of treatment-related adverse events in mRCC patients treated with first-line immune-checkpoint inhibitor combination therapy

T Tatsushi Kawada S Satoshi Katayama T Takafumi Yanagisawa K Keiichiro Mori W Wataru Fukuokaya K Kazumasa Komura T Takuya Tsujino R Ryoichi Maenosono K Kiyoshi Takahara T Takuhisa Nukaya L Lan Inoki S Shingo Toyoda T Takeshi Hashimoto (Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University) Y Yosuke Hirasawa K Kohei Edamura T Tomoko Kobayashi K Kensuke Bekku S Shingo Nishimura T Takehiro Iwata T Takuya Sadahira Y Yusuke Tominaga T Tomoaki Yamanoi K Kasumi Yoshinaga K Kazuma Tsuboi Y Yasuyuki Kobayashi A Atsushi Takamoto K Kyohei Kurose T Takahiro Kimura H Haruhito Azuma R Ryoichi Shiroki K Kazutoshi Fujita Y Yoshio Ohno M Motoo Araki